SCHEMBL12812555

SCHEMBL12812555

CN1CCC(CNC(=O)c2ccc(-c3cccc(CN(C)C(=O)CN)c3)cc2)CC1

nearest known ligand 0.67

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ AOC3 Q16853 20/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11423162 0.89 AOC3 (0.63) AOC3
SCHEMBL11422059 0.88 AOC3 (0.68) AOC3
SCHEMBL12814325 0.87 AOC3 (0.66) AOC3
SCHEMBL12812551 0.85 AOC3 (0.65) AOC3
SCHEMBL11363201 0.82 AOC3 (0.67) AOC3
SCHEMBL11426842 0.81 AOC3 (0.70) AOC3
SCHEMBL10317644 0.81 AOC3 (1.00) AOC3
SCHEMBL11422376 0.80 AOC3 (0.68) AOC3
SCHEMBL11371038 0.80 AOC3 (0.62) AOC3
SCHEMBL11366302 0.80 AOC3 (0.81) AOC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2479165-B1 GLYCINE COMPOUND ASTELLAS PHARMA INC (JP) 2017-10-25 — — EP disclosed
US-8802679-B2 Glycine compound ASTELLAS PHARMA INC. (JP) 2014-08-12 — — US disclosed
WO-2011034078-A1 GLYCINE COMPOUND アステラス製薬株式会社 (JP) 2011-03-24 — — WO disclosed
Send feedback